NewEdge Wealth LLC Takes Position in Encompass Health Corporation $EHC

NewEdge Wealth LLC purchased a new position in shares of Encompass Health Corporation (NYSE:EHC) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 5,113 shares of the company’s stock, valued at approximately $517,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its holdings in shares of Encompass Health by 21.5% in the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock valued at $8,960,000 after buying an additional 15,677 shares during the period. Millennium Management LLC grew its holdings in Encompass Health by 38.4% during the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after acquiring an additional 25,574 shares during the period. Caxton Associates LLP acquired a new position in Encompass Health during the first quarter worth $259,000. Walleye Capital LLC raised its position in Encompass Health by 667.6% in the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after acquiring an additional 7,671 shares in the last quarter. Finally, Gamco Investors INC. ET AL acquired a new stake in Encompass Health in the second quarter valued at $588,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on EHC shares. Weiss Ratings upgraded shares of Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 12th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research note on Friday, May 22nd. UBS Group boosted their price objective on shares of Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Barclays upped their target price on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Truist Financial increased their target price on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $148.71.

Insider Activity at Encompass Health

In related news, EVP John Patrick Darby sold 8,906 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of Encompass Health stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at $33,602,622.58. The trade was a 39.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $120.24 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. The business’s fifty day moving average price is $111.01 and its two-hundred day moving average price is $106.38. The stock has a market cap of $11.86 billion, a PE ratio of 19.58, a price-to-earnings-growth ratio of 2.44 and a beta of 0.72. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. The company had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, analysts forecast that Encompass Health Corporation will post 6.09 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.21 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 12.38%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.